| Issue Date | Title | Author(s) |
| 2021-08-01 | Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma. | Xiao, L; Somers, K; Murray, J; Pandher, R; Karsa, M; Ronca, E; Bongers, A; Terry, R; Ehteda, A; Gamble, LD; Issaeva, N; Leonova, KI; O'Connor, A; Mayoh, C; Venkat, P; Quek, H; Brand, J; Kusuma, FK; Pettitt, JA; Mosmann, E; Kearns, A; Eden, G; Alfred, S; Allan, S; Zhai, L; Kamili, A; Gifford, AJ; Carter, DR; Henderson, MJ; Fletcher, JI; Marshall, G; Johnstone, RW; Cesare, AJ; Ziegler, DS; Gudkov, AV; Gurova, KV; Norris, MD; Haber, M |
| 2019-01-30 | Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma | Gamble, LD; Purgato, S; Murray, J; Xiao, L; Yu, DMT; Hanssen, KM; Giorgi, FM; Carter, DR; Gifford, AJ; Valli, E; Milazzo, G; Kamili, A; Mayoh, C; Liu, B; Eden, G; Sarraf, S; Allan, S; Giacomo, SD; Flemming, CL; Russell, AJ; Cheung, BB; Oberthuer, A; London, WB; Fischer, M; Trahair, TN; Fletcher, JI; Marshall, GM; Ziegler, DS; Hogarty, MD; Burns, MR; Perini, G; Norris, MD; Haber, M |
| 2024-07-11 | The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. | Murray, JE; Valli, E; Milazzo, G; Mayoh, C; Gifford, AJ; Fletcher, JI; Xue, C; Jayatilleke, N; Salehzadeh, F; Gamble, LD; Rouaen, JRC; Carter, DR; Forgham, H; Sekyere, EO; Keating, J; Eden, G; Allan, S; Alfred, S; Kusuma, FK; Clark, A; Webber, H; Russell, AJ; de Weck, A; Kile, BT; Santulli, M; De Rosa, P; Fleuren, EDG; Gao, W; Wilkinson-White, L; Low, JKK; Mackay, JP; Marshall, GM; Hilton, DJ; Giorgi, FM; Koster, J; Perini, G; Haber, M; Norris, MD |
